Clinical Trial Update: Methylprednisolone N Acetylcysteine in Hepatic Resections [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating methylprednisolone combined with N-acetylcysteine in hepatic resection was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Ischemia-reperfusion Injury
• Liver Failure

Drugs mentioned

• Methylprednisolone N-acetylcysteine (Methylprednisolone; N-acetylcysteine)

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Ischemic Reperfusion Injury, Insufficiency; Hepatic, Postoperative | Phase 2 | Status: TERMINATED